A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)

• Ngā kaituhi matua: Susann Theile (Author), Julia Sidenius Johansen (Author), Dorte Lisbet Nielsen (Author), Benny Vittrup Jensen (Author), Carsten Palnæs Hansen (Author), Jane Preuss Hasselby (Author), Sverrir Vídalín Eiríksson (Author), Inna Markovna Chen (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

The antitumor activity of chitooligosaccharides has been suggested. This phase 2 trial evaluated the efficacy and safety of T-ChOS™, in addition to adjuvant chemotherapy, in patients after resection of pancreatic ductal adenocarcinoma (PDAC). In this single-center, randomized, double-blind, placebo-...